Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix vs LHRH Agonist in Prostate Cancer
NCT01674270Phase 2Completed
- Sponsor
- University Health Network
- Start
- Aug 2012
- Primary completion
- Dec 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of degarelix in prostate cancer (PCa), sponsored by University Health Network. Started Aug 2012; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01674270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674270.